Abstracts Archive - Page 2092 of 2607 - ACR Meeting Abstracts

Abstract Number: 2146 • 2014 ACR/ARHP Annual Meeting
Optimal Hand Position for Reliable Volumetric Joint Space Width Measurements Using High-Resolution Peripheral Quantitative Computed Tomography
Cheryl Barnabe¹, Sarah Manske², Britta Jorgenson² and Steven K. Boyd³, ¹Division of Rheumatology, University of Calgary, Calgary, AB, Canada, ²University of Calgary, Calgary, AB, Canada, ³Mechanical Engineering, University of Calgary, Calgary, AB, Canada
Background/Purpose: Joint space narrowing is an important outcome measure in rheumatoid arthritis, linked tightly to function and disability. High-resolution peripheral quantitative computed tomography (HR-pQCT) allows…
Abstract Number: 2147 • 2014 ACR/ARHP Annual Meeting
Automatically Extracted Quantitative Biomarkers for Assessing Connective Tissue Disease Using Nailfold Capillaroscopy
Michael Berks¹, Graham Dinsdale², Andrea Murray², Tonia Moore³, Chris Taylor¹ and Ariane Herrick², ¹Centre for Imaging Sciences, University of Manchester, Institute of Population Health, Manchester, United Kingdom, ²Centre for Musculoskeletal Research, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom, ³Salford Royal Hospital NHS Foundation Trust, Salford, United Kingdom
Background/Purpose Videomicroscopy can capture high-magnification images of nailfold capillaries, allowing non-invasive assessment of microvasculature change indicative of connective tissue disease. Whilst images may be qualitatively…
Abstract Number: 2148 • 2014 ACR/ARHP Annual Meeting
Dual Energy CT Scanning: Variable Sensitivity for Gout in Non-Tophaceous and Tophaceous Disease and in Individual Erosions
Tracie Kurano¹, Uma Thakur², Gaurav Thawait³, Elliot Fishman⁴, Mara McAdams-DeMarco⁵, Janet W. Maynard⁶, Matthew Fuld⁷, John A. Carrino⁸ and Alan N. Baer⁹, ¹Medicine-Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Musculoskeletal Radiology Section, Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, ³Musculoskeletal Radiology Section, Johns Hopkins University School of Medicine, Baltimore, MD, ⁴Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, ⁵Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, ⁶Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ⁷Research Collaborations - Computed Tomography R&D, Siemens Medical Solutions USA, Inc., Baltimore, MD, ⁸Radiology, Hospital for Special Surgery, New York, NY, ⁹Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD
Background/Purpose: Dual energy computed tomography (DECT) is emerging as a diagnostic tool for gout, but its sensitivity has not been established. We assessed the sensitivity…
Abstract Number: 2149 • 2014 ACR/ARHP Annual Meeting
Relationship Between the Magnitude of Bone Formation in the Anterior Vertebral Corners, As Assessed through 18F-Fluoride Uptake, and Lumbar Spine Bone Mineral Density in Patients with Ankylosing Spondylitis
Seung-Geun Lee¹, Eun-Kyoung Park¹, Geun-Tae Kim², Sang-Yeob Lee³ and Joung-Wokk Lee⁴, ¹Divsion of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, South Korea, ²Division of Rheumatology, Department of Internal Medicine, Kosin University College of Medicine, Busan, South Korea, ³Division of Rheumatology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, South Korea, ⁴Divsion of Rheumatology, Department of Internal Medicine, Busan St. Marys center, Busan, South Korea
Background/Purpose: 18F-fluoride uptake represents active osteoblastic bone synthesis. We investigated the relationship between the magnitude of bone formation in anterior vertebral corners, as assessed through…
Abstract Number: 2109 • 2014 ACR/ARHP Annual Meeting
Are Patient Ratings of Providers and Health Plans Associated with Technical Quality of Care in SLE?
Edward H. Yelin¹, Laura Trupin², Jinoos Yazdany² and Chris Tonner³, ¹Arthritis Research Group, University of California, San Francisco, San Francisco, CA, ²Medicine, University of California, San Francisco, San Francisco, CA, ³3333 California Street, Box 09, University of California, San Francisco, San Francisco, CA
Background/Purpose . Prior research has shown that the technical quality of SLE care is associated with the degree of subsequent accumulated damage. However, it is…
Abstract Number: 2111 • 2014 ACR/ARHP Annual Meeting
Overcoming Barriers to Acute Patient Access: Is There a Need for Urgent Care Clinics in Rheumatology Practices?
Ruchi Jain, Narender Annapureddy, Isabel Castrejón, Theodore Pincus, Daniel Garcia and Joel A. Block, Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: Urgent access for patients with rheumatic disease is limited in the United States, and it is often difficult to accommodate patients’ requests to be…
Abstract Number: 2112 • 2014 ACR/ARHP Annual Meeting
Patterns of Medication Use Before, During, and After Pregnancy Among Women with Systematic Lupus Erythematosus: A Population-Based Study
Mary De Vera¹, Eric C. Sayre², Corisande Baldwin³, Jessica Galo⁴ and J. Antonio Avina-Zubieta⁵, ¹University of British Columbia Faculty of Pharmaceutical Sciences, Vancouver, BC, Canada, ²Arthritis Research Centre of Canada, Richmond, BC, Canada, ³Rheumatology, University of British Columbia, Vancouver, BC, Canada, ⁴Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, ⁵Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada
Background/Purpose: Systemic lupus erythematosus (SLE) disproportionately affects women during childbearing years. Given the limited data on perinatal medication use among patients, our objective was…
Abstract Number: 2113 • 2014 ACR/ARHP Annual Meeting
The Number of Morbidities Drives the Health Care Expenditures and Presence of a Musculoskeletal Condition Is Additionally Accountable for Higher Costs
Antje van der Zee-Neuen¹, Polina Putrik², Sofia Ramiro³, Andras Keszei⁴, Astrid M. Chorus⁵, Rob de Bie⁶ and Annelies Boonen⁷, ¹Internal Medicine, Rheumatology, Maastricht University, Maastricht, Netherlands, ²Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ³Rheumatology, Amsterdam Rheumatology Center, University of Amsterdam & Hospital Garcia de Orta, Almada, Portugal, Amsterdam, Netherlands, ⁴Medical Informatics, RWTH Aachen University, Aachen, Germany, ⁵Netherlands Organization for Applied Scientific Research, Leiden, Netherlands, ⁶Epidemiology, Maastricht University, Maastricht, Netherlands, ⁷Maastricht University Medical Center, Maastricht, Netherlands
Background/Purpose: In Europe, 70- 80% of all healthcare expenses are attributable to chronic diseases and a large part of these are musculoskeletal conditions (MSKC).Having >1…
Abstract Number: 2114 • 2014 ACR/ARHP Annual Meeting
Comorbidity Characteristics of Patients Starting First-Line Acute Gout Agents – Colchicine, NSAID, and Corticosteroids
Alfonso Perez¹, Robert Jackson², Jiao Yang³, Aki Shiozawa⁴, Shawn Yu⁴, Yimin Qin¹, Huifang Liang⁵ and Hyon K. Choi⁶, ¹Global Clinical Science, Takeda Pharmaceuticals International, Inc, Deerfield, IL, ²Global Medical Office, Takeda Pharmaceuticals International, Inc, Deerfield, IL, ³Analytical Science, Takeda Pharmaceuticals International, Inc, Deerfield, IL, ⁴Global Outcomes and Epidemiology Research, Takeda Pharmaceuticals International, Inc, Deerfield, IL, ⁵Pharmacovigilance, Takeda Pharmaceuticals International, Inc, Deerfield, IL, ⁶Boston University School of Medicine, Boston, MA
Comorbidity Characteristics of Patients Starting First-Line Acute Gout Agents - Colchicine, NSAID, and CorticosteroidsBackground/Purpose: There is a remarkable, increasing disease burden of gout and its…
Abstract Number: 2115 • 2014 ACR/ARHP Annual Meeting
Inflammatory Arthritis Treatment Outcomes at a First Nations Reserve Rheumatology Specialty Clinic
Erin Bell¹, Sharon Leclercq², Dianne P. Mosher¹, Hani El-Gabalawy³, Tyler White⁴, Marvin Fritzler⁵ and Cheryl Barnabe², ¹University of Calgary, Calgary, AB, Canada, ²Division of Rheumatology, University of Calgary, Calgary, AB, Canada, ³Arthritis Centre, University of Manitoba, Winnipeg, MB, Canada, ⁴Siksika Health Services, Siksika, AB, Canada, ⁵Medicine, University of Calgary, Calgary, AB, Canada
Background/Purpose: Inflammatory arthritis (IA: rheumatoid arthritis, systemic lupus erythematosus, and spondyloarthritis) disproportionately affects Canada’s First Nations population. Treatment outcomes may be ameliorated by health service…
Abstract Number: 2116 • 2014 ACR/ARHP Annual Meeting
Hospitalization Rates and Utilization Among Rheumatoid Arthritis Patients: A Population-Based Study from 1987 to 2012
C. John Michet III¹, Katrina Strobova², Sara J. Achenbach³, Cynthia S. Crowson⁴ and Eric L. Matteson⁵, ¹Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN, ²Department of Medicine, Charles University, Prague, Czech Republic, ³Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ⁴Health Sciences Research, Mayo Clinic, Rochester, MN, ⁵Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose Patients with rheumatoid arthritis (RA) experience chronic management issues and are at risk for complex comorbidities. It is unknown, however, to what extent the…
Abstract Number: 2117 • 2014 ACR/ARHP Annual Meeting
Association Between Depression and High Utilization of Emergency Department in Patients with Systemic Lupus Erythematosus from the Southeastern United States: The Goal Cohort
Alfredo Aguirre¹, S. Sam Lim², Gaobin Bao³, Charles T. Molta⁴, Hong Kan⁵ and Cristina Drenkard⁶, ¹Department of Rheumatology, Emory University, Atlanta, GA, ²Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, ³Medicine, Emory University, Atlanta, GA, ⁴GlaxoSmithKline, King of Prussia, PA, ⁵5 Moore Dr, GSK, Durham, NC, ⁶Medicine, Div Rheumatology, Emory University, Atlanta, GA
Background/Purpose . Frequent visitors of the emergency department (ED) among the general population share several demographic, health system and disease characteristics, including older age, poverty,…
Abstract Number: 2118 • 2014 ACR/ARHP Annual Meeting
Lower Socioeconomic Status at Disease Onset Is Associated with Higher Health Care Costs in Patients with Systemic Lupus Erythematosus: A General Population-Based Cohort Study
Natalie McCormick¹, Mohsen Sadatsafavi², Wenjia Chen³, Carlo A. Marra⁴ and J. Antonio Avina-Zubieta⁵, ¹Faculty of Pharmaceutical Sciences, University of British Columbia/Arthritis Research Centre of Canada, Vancouver, BC, Canada, ²Division of Respiratory Medicine, University of British Columbia, Vancouver, BC, Canada, ³Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, ⁴Pharm Sciences, Univ of British Columbia, Vancouver, BC, Canada, ⁵Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada
Background/Purpose: Low socioeconomic status (SES) negatively impacts health outcomes in the general population, as well as in systemic lupus erythematosus (SLE), but the impact on…
Abstract Number: 2119 • 2014 ACR/ARHP Annual Meeting
Off Work Days Decreased RATE in Muskuloeskeletal Disease Patients: Usefulness of the EARLY Intervention Program
Francisco Miguel Ortiz Sanjuan, Isabel Martinez-Cordellat, Jose Ivorra, Jose Luis Valero, Inmaculada Chalmeta, Elena Grau, Carlos Feced, Rosa Negueroles, Luis Gonzalez-Puig, Cristobal Nuñez-Cornejo Piquer, Cristina Alcañiz, Eztizen Labrador and Jose Andres Roman Ivorra, Department of Rheumatology, Hospital Universitario y Politécnico La Fe., Valencia, Spain
Background/Purpose In March 2012, a new project was started at HUP La Fe following the pilot project carried out at San Carlos Clinical Hospital in…
Abstract Number: 2120 • 2014 ACR/ARHP Annual Meeting
Societal Preferences for Rheumatoid Arthritis Treatments. Evidence from a Discrete Choice Experiment
Mark Harrison^1,2, Carlo Marra³, Kam Shojania⁴ and Nick Bansback⁵, ¹University of Manchester, Manchester, United Kingdom, ²University of British Columbia, Vancouver, BC, Canada, ³Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, ⁴Medicine, University of British Columbia, Vancouver, BC, Canada, ⁵School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada
Background/Purpose The cost-effectiveness of new interventions is increasingly assessed using the cost per quality-adjusted life year (QALY). QALYs are calculated by multiplying the length of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].